PT1578731E - Processo para a preparação de compostos pirimidina - Google Patents

Processo para a preparação de compostos pirimidina Download PDF

Info

Publication number
PT1578731E
PT1578731E PT03780362T PT03780362T PT1578731E PT 1578731 E PT1578731 E PT 1578731E PT 03780362 T PT03780362 T PT 03780362T PT 03780362 T PT03780362 T PT 03780362T PT 1578731 E PT1578731 E PT 1578731E
Authority
PT
Portugal
Prior art keywords
preparation
pyrimidine compounds
pyrimidine
compounds
Prior art date
Application number
PT03780362T
Other languages
English (en)
Portuguese (pt)
Inventor
Lee Newton
Mark Bailey
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229243A external-priority patent/GB0229243D0/en
Priority claimed from GB0303589A external-priority patent/GB0303589D0/en
Priority claimed from GB0318515A external-priority patent/GB0318515D0/en
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of PT1578731E publication Critical patent/PT1578731E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT03780362T 2002-12-16 2003-12-09 Processo para a preparação de compostos pirimidina PT1578731E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0229243A GB0229243D0 (en) 2002-12-16 2002-12-16 Compounds and process
GB0303589A GB0303589D0 (en) 2003-02-17 2003-02-17 Compounds and process
GB0318515A GB0318515D0 (en) 2003-08-07 2003-08-07 Compounds and process

Publications (1)

Publication Number Publication Date
PT1578731E true PT1578731E (pt) 2010-01-12

Family

ID=32600665

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03780362T PT1578731E (pt) 2002-12-16 2003-12-09 Processo para a preparação de compostos pirimidina

Country Status (22)

Country Link
US (2) US7524955B2 (enExample)
EP (2) EP1578731B1 (enExample)
JP (2) JP4579821B2 (enExample)
KR (1) KR101060215B1 (enExample)
AR (1) AR042355A1 (enExample)
AT (1) ATE448209T1 (enExample)
AU (1) AU2003288443B2 (enExample)
BR (1) BR0317313A (enExample)
CA (1) CA2509344C (enExample)
CY (1) CY1110605T1 (enExample)
DE (1) DE60330050D1 (enExample)
DK (1) DK1578731T3 (enExample)
ES (1) ES2335279T3 (enExample)
IL (1) IL168884A (enExample)
MX (1) MXPA05006425A (enExample)
MY (1) MY138051A (enExample)
NO (2) NO330983B1 (enExample)
NZ (1) NZ540722A (enExample)
PT (1) PT1578731E (enExample)
SI (1) SI1578731T1 (enExample)
TW (1) TWI322145B (enExample)
WO (1) WO2004054986A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
KR100888408B1 (ko) 2001-07-13 2009-03-13 아스트라제네카 유케이 리미티드 아미노피리미딘 화합물의 제조 방법
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
KR20030092446A (ko) * 2002-05-29 2003-12-06 주식회사 한국토종약초연구소 씨형 간염 활성 억제를 갖는 조릿대 추출물을 포함하는조성물
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
DE60330050D1 (de) 2002-12-16 2009-12-24 Astrazeneca Uk Ltd Verfahren zur herstellung von pyrimidinverbindungen
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
US8153791B2 (en) * 2005-12-21 2012-04-10 Janssen Pharmaceutica N.V. Substituted pyrimidinyl oxime kinase inhibitors
WO2007109783A2 (en) * 2006-03-23 2007-09-27 Janssen Pharmaceutica, N.V. Substituted pyrimidine kinase inhibitors
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
MX2012013475A (es) 2010-05-21 2012-12-10 Cooper Technologies Co Adapatador para retenedor de buje.

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278001A (en) * 1965-02-02 1966-10-11 Charles C Andrews Bearing assembly for auger conveyors
US4698340A (en) 1984-07-19 1987-10-06 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives, processes for preparation thereof and composition containing the same
US4689414A (en) * 1986-02-24 1987-08-25 E. R. Squibb & Sons, Inc. 2-(substituted imino)-6-aryl-3,6-dihydro-4-substituted-1,5(2H)-pyrimidinecarboxylic acids and analogs
WO1990003973A1 (en) * 1988-10-06 1990-04-19 Sandoz Ag Pyrimidinyl-substituted hydroxyacids, lactones and esters and pharmaceutical compositions containing them
FR2665159B1 (fr) 1990-07-24 1992-11-13 Rhone Poulenc Sante Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
WO1993008823A1 (en) 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
JP3197971B2 (ja) * 1993-03-01 2001-08-13 塩野義製薬株式会社 5−カルボアルコキシピリミジン誘導体の合成方法
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
NZ264063A (en) 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
CA2205384C (en) 1994-11-16 2004-06-29 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
DE19517186A1 (de) * 1995-05-11 1996-11-14 Bayer Ag Verfahren zur Herstellung substituierter 2-Fluor-pyrimidine
US6278001B1 (en) 1995-11-28 2001-08-21 L'oréal Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping
FR2741620B1 (fr) 1995-11-28 1997-12-26 Oreal Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline
NZ326039A (en) 1995-12-14 1999-08-30 Merck & Co Inc Process for making 3,4-dihydro-pyrimidin-2(1h)-one derivatives
US5958934A (en) 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
SE9702563D0 (sv) 1997-07-02 1997-07-02 Astra Ab Compounds
EP1003734A2 (en) 1997-08-05 2000-05-31 Merck & Co., Inc. ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST
GB9903472D0 (en) * 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
WO2000078730A1 (en) 1999-06-23 2000-12-28 Ajinomoto Co., Inc. Novel dihydropyrimidine derivatives
CZ304307B6 (cs) 1999-07-13 2014-02-26 Lonza Ag Způsob výroby 2-amino-4-(4-fluorfenyl)-6-alkyl-pyrimidin-5-karboxylátu
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
AU2000254249A1 (en) 2000-03-28 2001-10-08 Biocon India Limited Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
GB0011163D0 (en) 2000-05-10 2000-06-28 Astrazeneca Ab Chemical compound
NL1015744C2 (nl) 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
KR100888408B1 (ko) * 2001-07-13 2009-03-13 아스트라제네카 유케이 리미티드 아미노피리미딘 화합물의 제조 방법
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
KR100511533B1 (ko) 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
DE60330050D1 (de) 2002-12-16 2009-12-24 Astrazeneca Uk Ltd Verfahren zur herstellung von pyrimidinverbindungen
WO2004103977A2 (en) 2003-05-21 2004-12-02 Ciba Specialty Chemicals Holding Inc. Process for the preparation of pyrimidine derivatives
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
CA2645396A1 (en) 2003-12-24 2005-07-14 Teva Pharmaceutical Industries, Ltd Process for preparation of statins with high syn to anti ratio
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process

Also Published As

Publication number Publication date
CA2509344C (en) 2011-10-04
KR20050085674A (ko) 2005-08-29
WO2004054986A2 (en) 2004-07-01
NO330983B1 (no) 2011-08-29
JP5318037B2 (ja) 2013-10-16
HK1080477A1 (en) 2006-04-28
EP2088142A2 (en) 2009-08-12
AU2003288443A1 (en) 2004-07-09
ATE448209T1 (de) 2009-11-15
JP4579821B2 (ja) 2010-11-10
DK1578731T3 (da) 2010-02-15
NZ540722A (en) 2008-03-28
NO20052781L (no) 2005-07-07
CY1110605T1 (el) 2015-04-29
TWI322145B (en) 2010-03-21
EP1578731B1 (en) 2009-11-11
EP2088142A3 (en) 2010-04-21
WO2004054986A8 (en) 2005-07-21
AU2003288443B2 (en) 2007-10-25
SI1578731T1 (sl) 2010-02-26
MY138051A (en) 2009-04-30
TW200418809A (en) 2004-10-01
US20090264654A1 (en) 2009-10-22
KR101060215B1 (ko) 2011-08-29
US8273878B2 (en) 2012-09-25
DE60330050D1 (de) 2009-12-24
JP2006515600A (ja) 2006-06-01
MXPA05006425A (es) 2005-08-19
NO20110366L (no) 2005-07-07
JP2010248222A (ja) 2010-11-04
EP1578731A2 (en) 2005-09-28
US7524955B2 (en) 2009-04-28
WO2004054986A3 (en) 2004-12-02
CA2509344A1 (en) 2004-07-01
AR042355A1 (es) 2005-06-15
ES2335279T3 (es) 2010-03-24
US20060052604A1 (en) 2006-03-09
BR0317313A (pt) 2005-11-08
IL168884A (en) 2011-01-31

Similar Documents

Publication Publication Date Title
HUP0500851A3 (en) Process for the preparation of rosuvastatin
TWI370811B (en) Process for the preparation of ring compounds
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
IL189657A (en) Process for the preparation of n-phenyl-2-pyrimidine-amine derivatives
IL166710A0 (en) Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile
SI1578731T1 (sl) Postopek za pripravo pirimidinskih spojin
AU2002307805A1 (en) Process for the preparation of cefdinir
EP1553090A4 (en) PROCESS FOR PREPARING A PYRIMIDINE COMPOUND
TWI347945B (en) Process for the preparation of thiazolopyrimidines
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
EG23973A (en) Process for the preparation of urea ganules
PL373627A1 (en) Process for the preparation of melamine
AU2002367890A1 (en) Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
AU2003225426A1 (en) Process for the preparation of urea
MY136695A (en) Process for the preparation of alkylaryl compounds
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
IL164788A0 (en) Process for the preparation of 3-isochromanone
AU2003256006A8 (en) Improved process for preparation of risperidone
IL161897A0 (en) Process for the preparation of cephalexin
ZA200603113B (en) Process for the preparation of risperidone
IL176471A0 (en) Process for the preparation of triazolopyrimidines
ZA200509495B (en) Process for the preparation of nicotinaldehydes
PL374911A1 (en) Process for the preparation of zaleplon